Search research articles
Contact Us
Filters
Showing results (641-650 of 733) with videos related to
Page
of 74
Sort By:
Advances in Skin & Wound Care
|
January 20, 2022
Quality Improvement Intervention Bundle Using the PUPPIES Acronym Reduces Pressure Injury Incidence in Critically Ill Patients
Jillian M McLaughlin, Jacquelynn P Tran, Samee A Hameed, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Annals of Surgery
|
June 14, 2012
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma
Georgia M Beasley, Colin Parsons, Gloria Broadwater, et al.
JAMA Network Open
|
June 27, 2023
Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans
Stephen B Williams, Jessica L Janes, Lauren E Howard, et al.
Biosensors & Bioelectronics
|
July 31, 2020
Measuring glucose at the site of insulin delivery with a redox-mediated sensor
Peter G Jacobs, Nichole S Tyler, Scott M Vanderwerf, et al.
Journal of Surgical Oncology
|
February 8, 2012
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Katia T Papalezova, Douglas S Tyler, Dan G Blazer, et al.
Nature Biotechnology
|
July 1, 1997
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor
P H Holden, V Asopa, A G Robertson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1990
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies
D S Tyler, S D Stanley, S Zolla-Pazner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma
Ryan S Turley, Andrew N Fontanella, James C Padussis, et al.
Journal of the American Geriatrics Society
|
January 4, 2012
Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer
Andrew S Barbas, Ryan S Turley, Eugene P Ceppa, et al.
Page
of 74
Search research articles
Search
Showing results (641-650 of 733) with videos related to
Sort By:
Page
of 74
Advances in Skin & Wound Care
|
January 20, 2022
Quality Improvement Intervention Bundle Using the PUPPIES Acronym Reduces Pressure Injury Incidence in Critically Ill Patients
Jillian M McLaughlin, Jacquelynn P Tran, Samee A Hameed, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Annals of Surgery
|
June 14, 2012
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma
Georgia M Beasley, Colin Parsons, Gloria Broadwater, et al.
JAMA Network Open
|
June 27, 2023
Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans
Stephen B Williams, Jessica L Janes, Lauren E Howard, et al.
Biosensors & Bioelectronics
|
July 31, 2020
Measuring glucose at the site of insulin delivery with a redox-mediated sensor
Peter G Jacobs, Nichole S Tyler, Scott M Vanderwerf, et al.
Journal of Surgical Oncology
|
February 8, 2012
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Katia T Papalezova, Douglas S Tyler, Dan G Blazer, et al.
Nature Biotechnology
|
July 1, 1997
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor
P H Holden, V Asopa, A G Robertson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1990
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies
D S Tyler, S D Stanley, S Zolla-Pazner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma
Ryan S Turley, Andrew N Fontanella, James C Padussis, et al.
Journal of the American Geriatrics Society
|
January 4, 2012
Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer
Andrew S Barbas, Ryan S Turley, Eugene P Ceppa, et al.
Page
of 74